Stocks and Investing
Stocks and Investing
Wed, June 27, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, June 26, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Adam Walsh Initiated (ASND) at Strong Buy and Held Target at $85 on, Jun 26th, 2018
Adam Walsh of Stifel, Initiated "Ascendis Pharma A/S" (ASND) at Strong Buy and Held Target at $85 on, Jun 26th, 2018.
Adam has made no other calls on ASND in the last 4 months.
There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Adam's Rating of Hold.
This is the rating of the analyst that currently disagrees with Adam
- Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $78 on, Tuesday, March 20th, 2018